Board of Directors

Edward Mackey
Chris Ramsden
Steve Maiocco
Ted Henderson

EDWARD MACKEY

Edward Mackey currently serves as Executive Vice President, Operations for Boston Scientific. He previously served as Worldwide President of DePuy Synthes Power Tools, a division of Johnson & Johnson following his roles of VP of Integration for Johnson & Johnson’s acquisition of Synthes and Worldwide VP of Supply Chain and Manufacturing at DePuy. Ed is a graduate of Worcester Polytechnic Institute with an MBA from the University of Massachusetts.

CHRIS RAMSDEN

Chris Ramsden served as Millstone’s Chief Executive Officer from 2004 to 2017. He currently serves on the Board of Directors at Resonetics, industry leader in laser micro manufacturing for life sciences.  Prior to Millstone, Chris served as Practice Director for Oracle Corporation in charge of New England’s Manufacturing and Distribution Consulting practice, Director of Operations for a privately held manufacturing company, Manager for KPMG Peat Marwick, and Lieutenant, Chief Engineer onboard a U.S. Navy Destroyer. Chris is a graduate of Dartmouth College with an MBA from the Kellogg School at Northwestern University.

STEVE MAIOCCO

Steve Maiocco has served as a Managing Director and the Chief Financial Officer at Schooner Capital since 1996.  He currently serves as a director at healthcare portfolio company, SRS Medical, and has previously served on the boards of several other Schooner Capital portfolio companies. Prior to Schooner, Steve spent fourteen years in public accounting at Tonneson & Company CPAs P.C. Steve is a graduate of Cornell University and has a Master’s of Science in Taxation degree from Bentley University. He is licensed as a Certified Public Accountant in the Commonwealth of Massachusetts.

TED HENDERSON

Ted Henderson has served as a Managing Director at Schooner Capital since 2004. He currently serves as a director at a number of portfolio companies, including healthcare sector holdings 4G Clinical, Cartesian Therapeutics, and SRS Medical. He previously led Schooner’s investment in Mimetogen (sold to Allergan), and served as a director at Topokine Therapeutics (sold to Allergan) and Best Doctors (sold to a private equity firm). Ted is a cum laude graduate of Dartmouth College with an MBA from Harvard Business School.